Heart failure remains one of the most pressing challenges in medicine, yet traditional approaches rely too heavily on late-stage indicators and reactive treatment. In this piece, Dr. Ries Robinson, CEO of Rodin Scientific and member of DocGo’s Medical Advisory Board, outlines the barriers that have slowed progress and highlights how remote monitoring tools like CardioMEMS and CIEDs can transform care.

Cardiac RMS by DocGo is advancing heart failure care with the integration of Abbott’s CardioMEMS device into its Remote Monitoring Program. By tracking pulmonary artery pressure, CardioMEMS offers up to a 30-day early warning of worsening heart failure, enabling earlier interventions and fewer hospitalizations. Supported by a nurse-led monitoring team and robust virtual care infrastructure, this program helps clinics scale proactive care while giving patients greater peace of mind at home.

Clinicians face rising complexity and shrinking time. As Dr. Robinson remarks, AI stays always on, learns each patient’s baseline, flags quiet deterioration, supports medication choices, and preserves institutional memory, while physicians provide context and judgment. Together they enable earlier, safer, more personalized care.